CONMED Corp (CNMD) earnings date
Feb 3, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 30 days, typically, give or take 3 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Oct 28, 2026 | after close | 28 | 8-K |
| Q2 FY2026 | Wed, Jul 29, 2026 | after close | 29 | 8-K |
| Q1 FY2026 | Wed, Apr 29, 2026 | after close | 29 | 8-K |
| Q4 FY2025 | Wed, Jan 28, 2026 | after close | 28 | 8-K |
| Q3 FY2025 | Wed, Nov 5, 2025 | after close | 36 | 8-K |
| Q2 FY2025 | Wed, Jul 30, 2025 | after close | 30 | 8-K |
| Q1 FY2025 | Wed, Apr 30, 2025 | after close | 30 | 8-K |
| Q4 FY2024 | Wed, Feb 5, 2025 | after close | 36 | 8-K |
What they guided beta
| Q3 FY2026 | "CONTACT : CONMED Corporation Investor Relations ir@conmed.com CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 Guidance Largo, Florida, October 28, 2026 – CONMED Corporation (NYSE: CNMD) today reported financial results for the third quarter ended September 30, 2026 and updated its financial guidance for the full year ending 2026." exhibit |
| Q3 FY2026 | "With a sharpened strategic focus on these key markets following our recent portfolio optimization activities, CONMED is better positioned to support our customers, expand our market share, and drive both long-term growth and value creation going forward." 2026 Financial Guidance The Company is updating its full year 2026 financial guidance to reflect its third quarter performance and updated outlook for the full year." exhibit |
| Q3 FY2026 | "For the twelve months ended December 31, 2026, the Company now expects: Dollars in millions, except per share figures Percentages on a year-over-year basis, may not foot due to rounding Twelve Months Ending December 31, 2026 Updated Financial Guidance Prior Financial Guidance (5) Low High Low High Net Sales (GAAP) $ 1,360 $ 1,366 $ 1,358 $ 1,373 Net Sales Growth, as reported (1.1) % (0.6) % (1.2) % (0.1) % Estimated impact of foreign currency exchange rate fluctuations (0.7) % (0.7) % (0.5) % (0.5) % Net Sales Growth, Constant Currency (1.7) % (1.3) % (1.7) % (0.7) % Estimated impact of st" exhibit |
| Q3 FY2026 | "(5) "Prior financial guidance" reflects the Company’s full year 2026 financial guidance, previously updated on July 29, 2026." exhibit |
| Q2 FY2026 | "CONTACT : CONMED Corporation Investor Relations ir@conmed.com CONMED Corporation Reports Second Quarter 2026 Financial Results; Updates Full Year 2026 Guidance Largo, Florida, July 29, 2026 – CONMED Corporation (NYSE: CNMD) today reported financial results for the second quarter ended June 30, 2026 and updated its financial guidance for the full year ending 2026." exhibit |
| Q2 FY2026 | "Beyer continued: "We are updating our financial guidance for the full year 2026 today to reflect both our second quarter performance and our updated outlook for the balance of the year." exhibit |
| Q2 FY2026 | "Looking ahead, our team remains focused on disciplined execution as we continue to position CONMED for quality, long-term growth and value creation." 2026 Financial Guidance The Company is updating its full year 2026 financial guidance to reflect its second quarter performance and updated outlook for the second half of 2026." exhibit |
| Q2 FY2026 | "For the twelve months ended December 31, 2026, the Company now expects: Dollars in millions, except per share figures Percentages on a year-over-year basis, may not foot due to rounding Twelve Months Ending December 31, 2026 Updated Financial Guidance Prior Financial Guidance (5) Low High Low High Net Sales (GAAP) $ 1,358 $ 1,373 $ 1,350 $ 1,375 Net Sales Growth, as reported (1.2) % (0.1) % (1.8) % 0.0 % Estimated impact of foreign currency exchange rate fluctuations (0.5) % (0.5) % (0.3) % (0.5) % Net Sales Growth, Constant Currency (1.7) % (0.7) % (2.1) % (0.5) % Estimated impact of stra" exhibit |
| Q2 FY2026 | "(5) "Prior financial guidance" reflects the Company’s full year 2026 financial guidance, previously updated on April 29, 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CNMD
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CNMD
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/CNMD/"><img src="https://veritasdata.dev/embed/CNMD.svg" alt="CNMD earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/CNMD/)
Script
<script async src="https://veritasdata.dev/embed/CNMD.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CNMD"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.